KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Acquisitions: 2009-2016

Historic Acquisitions for Biomarin Pharmaceutical (BMRN) over the last 5 years, with Dec 2016 value amounting to $2.8 million.

  • Biomarin Pharmaceutical's Acquisitions was N/A to $1.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $568.4 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2016, which is 99.48% down from last year.
  • Biomarin Pharmaceutical's Acquisitions amounted to $2.8 million in FY2016, which was down 99.48% from $538.4 million recorded in FY2015.
  • In the past 5 years, Biomarin Pharmaceutical's Acquisitions ranged from a high of $538.4 million in FY2015 and a low of $2.8 million during FY2016.
  • Moreover, its 2-year median value for Acquisitions was $270.6 million (2015), whereas its average is $270.6 million.
  • Data for Biomarin Pharmaceutical's Acquisitions shows a maximum YoY tumbled of 99.48% (in 2016) over the last 5 years.
  • Yearly analysis of 3 years shows Biomarin Pharmaceutical's Acquisitions stood at $9.9 million in 2013, then reached $538.4 million in 2015, then tumbled by 99.48% to $2.8 million in 2016.